Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review. (January 2022)
- Record Type:
- Journal Article
- Title:
- Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review. (January 2022)
- Main Title:
- Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review
- Authors:
- Schneider, Lucas
Laiouar-Pedari, Sara
Kuntz, Sara
Krieghoff-Henning, Eva
Hekler, Achim
Kather, Jakob N.
Gaiser, Timo
Fröhling, Stefan
Brinker, Titus J. - Abstract:
- Abstract: Background: Over the past decade, the development of molecular high-throughput methods (omics) increased rapidly and provided new insights for cancer research. In parallel, deep learning approaches revealed the enormous potential for medical image analysis, especially in digital pathology. Combining image and omics data with deep learning tools may enable the discovery of new cancer biomarkers and a more precise prediction of patient prognosis. This systematic review addresses different multimodal fusion methods of convolutional neural network-based image analyses with omics data, focussing on the impact of data combination on the classification performance. Methods: PubMed was screened for peer-reviewed articles published in English between January 2015 and June 2021 by two independent researchers. Search terms related to deep learning, digital pathology, omics, and multimodal fusion were combined. Results: We identified a total of 11 studies meeting the inclusion criteria, namely studies that used convolutional neural networks for haematoxylin and eosin image analysis of patients with cancer in combination with integrated omics data. Publications were categorised according to their endpoints: 7 studies focused on survival analysis and 4 studies on prediction of cancer subtypes, malignancy or microsatellite instability with spatial analysis. Conclusions: Image-based classifiers already show high performances in prognostic and predictive cancer diagnostics. TheAbstract: Background: Over the past decade, the development of molecular high-throughput methods (omics) increased rapidly and provided new insights for cancer research. In parallel, deep learning approaches revealed the enormous potential for medical image analysis, especially in digital pathology. Combining image and omics data with deep learning tools may enable the discovery of new cancer biomarkers and a more precise prediction of patient prognosis. This systematic review addresses different multimodal fusion methods of convolutional neural network-based image analyses with omics data, focussing on the impact of data combination on the classification performance. Methods: PubMed was screened for peer-reviewed articles published in English between January 2015 and June 2021 by two independent researchers. Search terms related to deep learning, digital pathology, omics, and multimodal fusion were combined. Results: We identified a total of 11 studies meeting the inclusion criteria, namely studies that used convolutional neural networks for haematoxylin and eosin image analysis of patients with cancer in combination with integrated omics data. Publications were categorised according to their endpoints: 7 studies focused on survival analysis and 4 studies on prediction of cancer subtypes, malignancy or microsatellite instability with spatial analysis. Conclusions: Image-based classifiers already show high performances in prognostic and predictive cancer diagnostics. The integration of omics data led to improved performance in all studies described here. However, these are very early studies that still require external validation to demonstrate their generalisability and robustness. Further and more comprehensive studies with larger sample sizes are needed to evaluate performance and determine clinical benefits. Highlights: Fusion of image and genomic data with deep learning improves performance. Several studies showed a benefit for cancer research. The studies are at a very early stage and require external validation. Further studies are needed to demonstrate clinical benefits. … (more)
- Is Part Of:
- European journal of cancer. Volume 160(2022)
- Journal:
- European journal of cancer
- Issue:
- Volume 160(2022)
- Issue Display:
- Volume 160, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 160
- Issue:
- 2022
- Issue Sort Value:
- 2022-0160-2022-0000
- Page Start:
- 80
- Page End:
- 91
- Publication Date:
- 2022-01
- Subjects:
- Cancer -- Biomarker identification -- Convolutional neural networks -- Omics -- Multimodal fusion
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejca.2021.10.007 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20262.xml